Summary
The influence of drug-drug and drug-food interactions affecting the absorption of orally administered medication is reviewed. Drug-drug interactions can be classified in terms of indirect effects by one drug on gastrointestinal tract physiology influencing the absorption of other drugs, or direct interactions involving altered pH, adsorption, absorption, or chelation. Most, but not all, drug-drug interactions result in reduced or delayed systemic drug availability.
Drug-food interactions may result in reduced, delayed, or increased systemic drug availability. The absorption of only a small number of drugs is unaffected by concomitant food intake. The degree of interaction and whether it positively or negatively affects drug absorption depends on a number of factors including the physical and chemical nature of the drug, the formulation, the type of meal, and the time interval between eating and dosing.
Mechanisms of drug-food interactions are not well characterised. They clearly involve both direct and indirect factors in a similar fashion to drug-drug interactions, but indirect factors probably predominate. Reduced or delayed drug absorption is generally attributed, at least in part, to delayed stomach-emptying due to food. Increased absorption may also result from delayed stomach-emptying facilitating greater drug dissolution before it passes from the stomach into the small intestine. Increased bioavailability of some drugs, e.g. propranolol, metoprolol and labetalol, may be related to reduced presystemic clearance.
The potential clinical implications of drug-drug and drug-food interactions must be taken into account with oral medications in order to minimise variations in systemic drug availability and hence in clinical efficacy.
Similar content being viewed by others
References
Adjepon-Yamoah, K.K.; Scott, D.B. and Prescott, L.F.: Impaired absorptio. and metabolism of oral lignocaine in patients undergoing laparoscopy. British Journal of Anaesthesia 45: 143–147 (1973).
Albert, K.S.; Ayres, J.W.; DiSanto, A.R.; Weidler, D.J.; Sakmar, E.; Hallmark, M.R.; Stoll, R.G.; DeSante, K.A. and Wagner, J.G.: Influence of kaolin-pectin suspension of digoxin bioavailability. Journal of Pharmaceutical Sciences 67: 1582–1585 (1978a).
Albert, K.S.; DeSante, K.A.; Welch, R.D. and DiSanto, A.R.: Pharmacokinetic evaluation of a drug interaction between kaolin, pecti. and clindamycin. Journal of Pharmaceutical Sciences 67: 1579–1582 (1978b).
Ambre, J.J. and Fischer, L.J.: Effect of coadministration of aluminiu. and magnesium hydroxides on absorption of anticoagulants in man. Clinical Pharmacolog. and Therapeutics 14: 231–237 (1973).
Ameer, B.; Polk, R.E.; Kline, B.J. and Grisafe, J.P.: Effect of food on ethambutol absorption. Clinical Pharmacy 1: 156–158 (1982).
Antonioli, J.A.; Schelling, J.L.; Steininger, E. and Borel, G.A.: Effect of gastrectom. and of an anticholinergic drug on the gastrointestinal absorption of a sulfonamide in man. International Journal of Clinical Pharmacology 5: 212–215 (1971).
Barbhaiya, R.H.; Craig, W.A.; Corrick-West, H.P. and Welling, P.G.: Pharmacokinetics of hydrochlorothiazide in faste. and nonfasted subjects: A comparison of plasma leve. and urinary excretion methods. Journal of Pharmaceutical Sciences 71: 245–248 (1982).
Barlow, O.W. and Climenko, D.R.: Studies on the pharmacology of sulfapyridin. and sulfathiazole. Journal of the American Medical Association 116: 282–286 (1941).
Barr, W.H.; Adir, J. and Garrettson, L.: Decrease in tetracycline absorption in man by sodium bicarbonate. Clinical Pharmacolog. and Therapeutics 12: 779–784 (1971).
Barrowman, J.A.; D’Mello, A. and Herxheimer, A.: A single dose of neomycin impairs absorption of vitamin A (retinol) in man. European Journal of Clinical Pharmacology 5: 199–202 (1973).
Bates, T.R.; Sequeira, J.A. and Tembo, A.V.: Effect of food on nitrofurantoin absorption. Clinical Pharmacolog. and Therapeutics 16: 63–68 (1974).
Bechtol, L.D.; Bessent, C.T. and Perkal, M.B.: The influence of food on the absorption of erythromycin ester. and entericcoated erythromycin in single-dose studies. Current Therapeutic Research 25: 618–625 (1979).
Beerman, B. and Groschinsky-Grind, M.: Pharmacokinetics of hydrochlorothiazide in man. European Journal of Clinical Pharmacology 12: 297–303 (1977).
Beerman, B. and Groschinsky-Grind, M.: Enhancement of the gastrointestinal absorption of hydrochlorothiazide by pro-pantheline. European Journal of Clinical Pharmacology 13: 385–387 (1978a).
Beerman, B. and Groschinsky-Grind, M.: Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. European Journal of Clinical Pharmacology 13: 125–128 (1978b).
Beermann, B.; Groschinsky-Grind, M. and Lindstrom, B.: Effect of food on the bioavailability of bendroflumethiazide. Acta Medica Scandinavica 204: 291–293 (1978).
Ben-Ishay, D. and Engleman, K.: Bioavailability of potassium from a slow-release tablet. Clinical Pharmacolog. and Therapeutics 14: 250–258 (1973).
Bergan, T.: Pivampicillin (Pondocillin) a new alternative to ampicillin. Tidsskrift for den Norske Laegeforening 92: 503–504 (1972).
Berlin, H. and Brante, G.: Studies on oral utilization of penicillin V; in Antibiotics Annual, 1958–1959, pp. 149–157 (Medical Encyclopedia Inc., 1959).
Black, H.R.; Israel, K.S.; Wolen, R.L.; Brier, G.L.; Obermeyer, B.D.; Ziege, E.A. and Wolny, J.D.: Pharmacology of cinox-acin in humans. Antimicrobial Agent. and Chemotherapy 15: 165–170 (1979).
Bodemar, G.; Norlander, B.; Fransson, L. and Walan, A.: The absorption of cimetidine befor. and during maintenance treatment with cimetidin. and the influence of a meal on the absorption of cimetidine. Studies in patients with peptic ulcer disease. British Journal of Clinical Pharmacology 7: 23–31 (1979).
Bogentoft, G; Carlsson, I.; Ekenved, G., Magnusson, A.: Influence of food on the absorption of acetylsalicylic acid from enteric coated dosage forms. European Journal of Clinical Pharmacology 14: 351–355 (1978).
Boman, G.; Hanngren, Å.; Malmborg, A.-S.; Borgå, O. and Sjöqyist, F.: Drug interaction: Decreased serum concentrations of rifampicin when given with P.A.S. Lancet 2: 800 (1971).
Boman, G.; Lundgren, P. and Stjernström, G.: Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: Adsorption of rifampicin by an excipient bentonite. European Journal of Clinical Pharmacology 8: 293–299 (1975).
Bradbrook, I.D.; Morrison, P.J. and Rogers, H.J.: The effect of bromelain on the absorption of orally administered tetracycline. British Journal of Clinical Pharmacology 6: 552–554 (1978).
Brise, H.: Influence of meals on iron absorption in oral iron therapy. Acta Medica Scandinavica 171 (Suppl. 376): 39–45 (1962).
Brown, D.D. and Juhl, R.P.: Decreased bioavailability of digoxin due to antacid. and kaolin-pectin. New England Journal of Medicine 295: 1034–1037 (1976).
Caldwell, J.H.; Bush, C.A. and Greenberger, N.J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxi. and cardiac systolic intervals in man. Journal of Clinical Investigation 50: 2638–2644 (1971).
Cheng, S.H. and White, A.: Effect of orally administered neomycin on the absorption of penicillin V. New England Journal of Medicine 267: 1296–1297 (1962).
Chun, A.H.C.; Hoffman, D.J.; Friedmann, N. and Carrigan, P.J.: Bioavailability of valproic acid under fasling/nonfasting regimens. Journal of Clinical Pharmacology 20: 30–36 (1980).
Conney, A.H.; Pantuck, E.J.; Hsiao, K.-C; Carland, W.A.; Anderson, K.E.; Alvares, A.P. and Kappas, A.: Enhanced phen-acetin metabolism in human subjects fed charcoal-broiled beef. Clinical Pharmacolog. and Therapeutics 20: 633–642 (1976).
Corby, D.G. and Decker, W.J.: Management of acute poisoning with activated charcoal. Pediatrics 54: 324–328 (1974).
Coyne, T.C.; Shum, S.; Chun, A.H.C.; Jeansonne, L. and Shirkey, H.C.: Bioavailability of erythromycin ethylsuccinate in pediatric patients. Journal of Clinical Pharmacology 18: 194–202 (1978).
Crammer, J.L.; Rosser, R.M. and Crane, G.: Blood level. and management of lithium treatment. British Medical Journal 3: 650–654 (1974).
Cronk, G.A.; Naumann, D.E.; Albright, H. and Wheatley, W.B.: Laborator. and clinical studies with potassium-152 [potassium (α-phenoxyethyl)-penicillin]; in Antibiotics Annual, 1959–1960, pp. 133–145 (Medical Encyclopaedia Inc., 1960).
Cronk. G.A.; Wheatley, W.B.; Fellers, G.F. and Albright, H.: The relationship of food intake to the absorption of potassium alpha-phenoxyethyl penicilli. and potassium phenoxymethyl penicillin from the gastrointestinal tract. American Journal of Medical Science 240: 219–225 (1960).
Crounse, R.G.: Human pharmacology of griseofulvin: The effect of fat intake on gastrointestinal absorption. Journal of Investigative Dermatology 37: 529–533 (1961).
Dawes, C.P.; Kendall, M.J. and Welling, P.G.: Bioavailability of conventiona. and slow-release oxprenolol in faste. and non-fasted individuals. British Journal of Clinical Pharmacology 7: 299–302 (1979).
De Smet, P.A.G.; De Gier, J.J. and Nelemans, F.A.: De invloed van voeding op de resorptie, het metabolisme en de geneesmiddelen. Huisaris en Wetenschap 21: 176–179 (1978).
DiSanto, A.R. and Chodos, D.J.: Influence of study design in assessing food effects on absorption of erythromycin bas. and erythromycin stearate. Antimicrobial Agent. and Chemotherapy 20: 190–196 (1981).
Ehrsson, H.; Nilsson, S.O.; Ehrnebo, M.; Wallin, I. and Wennersten, G.: Effect of food on kinetics of 8-methoxsalen. Clinical Pharmacolog. and Therapeutics 25: 167–171 (1979).
Elliott, H.L.; Meredith, P.A.; McLean, K.; Hughes, M.A. and Reid, J.L.: The effect of food on the pharmacokinetic. and pharmacodynamics of tolmesoxide in essential hypertensives. European Journal of Clinical Pharmacology 21: 287–291 (1982).
Eshelman, F.N. and Spyker, D.A.: Pharmacokinetics of amoxicilli. and ampicillin: Crossover study of the effect of food. Antimicrobial Agent. and Chemotherapy 14: 539–543 (1978).
Faloon, W.W. and Chodos, R.B.: Vitamin B12 absorption studies using colchicine, neomyci. and continuous 57Co B12 administration. Gastroemerology 56: 1251 (1969).
Fann, W.E.; Davis, J.M.; Janowsky, D.S.; Sekerke, H.J. and Schmidt, D.M.: Chlorpromazine: Effects of antacids on its gastrointestinal absorption. Journal of Clinical Pharmacology 13: 388–390 (1973).
Federal Register: Drug Products. Bioequivalence requirement. and in vivo bioavailability procedures 42: 1624–1653 (1977).
Feldman, S. and Carlstedt, B.C.: Effect of antacid on absorption of enteric-coated aspirin. Journal of the American Medical Association 227: 660–661 (1974).
Fermaglich, J. and O’Doherty, D.S.: Effect of gastric motility on levodopa- Diseases of the Nervous System 33: 624–625 (1972).
Fernandez, C.A.; Menezes, J.P. and Ximenes, J.: The effect of food on the absorption of pivampicilli. and a comparison with the absorption of ampicillin potassium. Journal of International Medical Research 1: 530–533 (1973).
Foltz, E.L.; West, J.W.; Breslow, I.H. and Wallick, H.: Clinical pharmacology of pivampicillin. Antimicrobial Agent. and Chemotherapy 1970: 442–453 (1971).
Forrest, F.M.; Forrest, I.S. and Serra, M.T.: Modification of chlorpromazine metabolism by some other drugs frequently administered to psychiatric patients. Biological Psychiatry 2: 53–58 (1970).
Gibaldi, M. and Grundhofer, B.: Biopharmaceutic influences on the anticholinergic effects of propantheline. Clinical Pharmacolog. and Therapeutics 18: 457–461 (1975).
Gibbons, D.O. and Lant, A.F.: Effects of intravenou. and oral propanthelin. and metoclopramide on ethanol absorption. Clinical Pharmacolog. and Therapeutics 17: 578–584 (1975).
Gillespie, N.G.; Mena, I.; Cotzias, G.C. and Bell, M.A.: Diets affecting treatment of parkinsonism with levodopa. Journal of the American Dietetic Association 62: 525–528 (1973).
Ginsburg, C.M.; McCracke, Jr, G.H.; Thomas, M.L. and Clahsen, J.: Comparative pharmacokinetics of amoxicilli. and ampicillin in infant. and children. Pediatrics 64: 627–631 (1979).
Glynne, A.; Goulbourn, R.A. and Ryden, R.: A human pharmacology of cefaclor. Journal of Antimicrobial Chemotherapy 4: 343–348 (1978).
Gothoni, G.; Neuvonen, P.J.; Mattila, M. and Hackman, R.: Irontetracycline interaction: Effect of time interval between the drugs. Acta Medica Scandinavica 191: 409–411 (1972).
Gouda, M.W.: Effect of an antidiarrheal mixture on the bioavailability of tetracyclin. and ampicillin. Abstracts of 21st meeting of Academy of Pharmaceutical Sciences 6: 117 (1976).
Greenblatt, D.J.; Allen, M.D.; MacLaughlin, D.S.; Harmatz, J.S. and Shader, R.I.: Diazepam absorption: Effect of antacid. and food. Clinical Pharmacolog. and Therapeutics 24: 600–609 (1978).
Greenblatt, D.J.: Duhme, D.W.: Koch-Weser, J. and Smith, T.W.: Bioavailability of digoxin tablet. and elixir in the fastin. and postprandial states. Clinical Pharmacolog. and Therapeutics 16: 444–448 (1974).
Greenblatt, D.J.; Shader, R.I.; Harmatz, J.S.; Franke, K. and Koch-Weser, J.: Influence of magnesiu. and aluminium hydroxide mixture on chlordiazepoxide absorption. Clinical Pharmacolog. and Therapeutics 19: 234–239 (1976).
Greenspan, R.; MacLean, H.; Milzer, A. and Necheles, H.: Antacid. and Aureomycin. American Journal of Digestive Diseases 18: 35–37 (1951).
Griffith, R.S.; Joiner, M. and Kottlowski, H.: Comparison of antibacterial activity in the sera of subjects ingesting propionyl erythromycin lauryl sulfat. and erythromycin ethyl carbonate. Antibiotic Medicin. and Clinical Therapy 7: 320–326 (1960).
Haginaka, J.; Yamaoka, K.; Nakagama, T.; Nishimura, Y. and Uno, T.: Evaluation of food ingestion on bioavailability of cephalexin by moment analysis. Chemica. and Pharmaceutical Bulletin (Tokyo) 27: 3156–3159 (1979).
Harcourt, R.S. and Hamburger, M.: The effect of magnesium sulfate in lowering tetracycline blood levels. Journal of Laborator. and Clinical Medicine 50: 464–468 (1957).
Harvengt, C.; de Schepper, P.; Lamy, F. and Hansen, J.: Cephradine absorptio. and excretion in fastin. and nonfasting volunteers. Journal of Clinical Pharmacology 13: 36–40 (1973).
Hasegawa, J.; Tomono, Y.; Fujita, T.; Sugiyama, K. and Hamamura, K.: The effect of food on the absorption of α-to-copheryl nicotinate in beagle dog. and human volunteers. International Journal of Clinical Pharmacology 19: 216–219 (1981).
Hayden, J.W. and Comstock, E.G.: Use of activated charcoal in acute poisoning. Clinical Toxicology 8: 515–533 (1975).
Heading, R.C.; Nimmo, J.; Prescott, L.F. and Tothill, P.: The dependence of paracetamol absorption on the rate of gastric emptying. British Journal of Pharmacology 47: 415–421 (1973).
Heimann, G.; Murgescu, J. and Bergt, U.: Influence of food intake on bioavailability of theophylline in premature infants. European Journal of Clinical Pharmacology 22: 171–173 (1982).
Heinivaara, O. and Palva, I.P.: Malabsorptio. and deficiency of B12 caused by treatment with para-aminosalicylic acid. Acta Medica Scandinavica 177: 337–341 (1965).
Heinrich, H.C.; Oppitz, K.H. and Gabbe, E.E.: Hemmung der Eisenabsorption beim Menshcen durch Tetracyclin. Klinische Wochenschrift 52: 493–498 (1974).
Hoffman, W.S. and Dyniewicz, H.A.: The effect of alumina gel upon the absorption of vitamin A from the intestinal tract. Gastroenterology 5: 512–522 (1945).
Hurwitz, A.: The effects of antacids on gastrointestinal drug absorption II. Effect on sulfadiazin. and quinine. Journal of Pharmacolog. and Experimental Therapeutics 179: 485–490 (1971).
Hurwitz, A. and Schlozman, D.L.: Effects of antacids on gastrointestinal absorption of isoniazid in ra. and man. American Review of Respiratory Diseases 109: 41–47 (1974).
Ishizaki, T.; Nomura, T. and Abe, T.: Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fastin. and postprandial states in man. Journal of Pharmacokinetic. and Biopharmaceutics 7: 369–381 (1979).
Jaffe, J.J.; Colaizzi, J.L. and Barry, H.: Effects of dietary components on GI absorption of acetaminophen tablets in man. Journal of Pharmaceutical Sciences 60: 1646–1650 (1971).
Jeppson, J. and Sjögren, J.: The influence of food on side effect. and absorption of lithium. Acta Psychiatrica Scandinavica 51: 285–288 (1975).
Johnson, B.F.; O’Grady, J.; Sabey, G.A. and Bye, C.: Effect of a standard breakfast on digoxin absorption in normal subjects. Clinical Pharmacolog. and Therapeutics 23: 315–319 (1978).
Jordan, M.C.; de Maine, J.B. and Kirby, W.M.M.: Clinial pharmacology of pivampicillin as compared with ampicillin. Antimicrobial Agent. and Chemotherapy 10: 438–441 (1981).
Jusko, W.J. and Levy, G.: Absorption, metabolis. and excretion of riboflavin-5′-phosphate in man. Journal of Pharmaceutical Sciences 56: 58–62 (1967).
Jusko, W.J. and Lewis, G.P.: Comparison of ampicilli. and hetacillin pharmacokinetics in man. Journal of Pharmaceutical Sciences 62: 69–76 (1973).
Kabasakalian, P.; Katz, M.; Rosenkrantz, B. and Townley, E.: Parameters affecting absorption of griseofulvin in a human subject using urinary metabolite excretion data. Journal of Pharmaceutical Sciences 59: 595–600 (1970).
Kahela, P.; Antilla, M.; Tikkanen, R. and Sundquist, H.: Effect of food, food constituent. and fluid volume on the bioavail-ability of sotalol. Acta Pharmacologica et Toxicoligica 44: 7–12 (1979)
Kamme, C.; Kahlmeter, G. and Melander, A.: Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Scandinavian Journal of Infectious Diseases 10: 135–142 (1978).
Kappas, A.; Alvares, A.P.; Anderson, K.E.; Pantuck, E.J.; Pantuck, C.B.; Chang, R. and Conney, A.H.: Effect of charcoal-broiled beef on antipyrin. and theophylline metabolism. Clinical Pharmacolog. and Therapeutics 23: 445–450 (1978).
Kauffman, R.E. and Azarnoff, D.L.: Effect of colestipol on gastrointestinal absorption of chlorothiazide in man. Clinical Pharmacolog. and Therapeutics 14: 886–889 (1973).
Kaumeier, S.: The effect of the composition of food on the absorption of sulfameter. International Journal of Clinical Pharmacology 17: 260–263 (1979).
Kaumeier, S.: Kisslinger, E. and Neiss, A.: The effect of gastrointestinal filling on the absorption of sulfamethoxydiazine. International Journal of Clinical Pharmacology 17: 412–415 (1979).
Kelly, M.R.; Cutler, R.E.; Forrey, A.W. and Kimpel, B.M.: Pharmacokinetics of orally administered furosemide. Clinical Pharmacolog. and Therapeutics 15: 178–186 (1974).
Koch, P.A.; Schultz, C.A.; Wills, R.J.; Hallquist, S.L. and Welling, P.G.: Influence of foo. and fluid ingestion on aspirin bioavailability. Journal of Pharmaceutical Sciences 67: 1533–1535 (1978).
Lavigne, J.-G. and Marchand, C.: Inhibition of gastrointestinal absorption of p-aminosalicylate (PAS) in rat. and humans by diphenhydramine. Clinical Pharmacolog. and Therapeutics 14:404–411 (1973).
Leeds, N.H.; Gal, P.; Purohit, A.A. and Walter, J.B.: Effect of food on the bioavailabilit. and pattern of release of a sustained-release theophylline tablet. Journal of Clinical Pharmacology 22: 196–200 (1982).
Levy, G. and Jusko, W.J.: Factors affecting the absorption of ribo-flavin in man. Journal of Pharmaceutical Sciences 55: 285–289 (1966).
Levy, R.H.; Pitlick, W.H.; Troupin, A.S.; Green, J.R. and Neal, J.M.: Pharmacokientics of carbamazepine in normal man. Clinical Pharmacolog. and Therapeutics 17: 657–668 (1975).
Levy, G. and Rao, B.K.: Enhanced intestinal absorption of ribo-flavin from sodium alginate solution in man. Journal of Pharmaceutical Sciences 61: 279–280 (1972).
Levy, G. and Tsuchiya, T.: Effect of activated charcoal on aspirin absorption in ma, Part 1. Clinical Pharmacolog. and Therapeutics 13: 317–322 (1972).
Lindenbaum, J.; Maulitz, R.M.; Saha, J.R.; Shea, N. and Butler, V.P.: Impairment of digoxin absorption by neomycin. Clinical Research 20: 410 (1972).
Lucarotti, R.L.; Colaizzi, J.L.; Barry, H. and Poust, R.I.: Enhanced pseudoephedrine absorption by concurrent administration of aluminium hydroxide gel in humans. Journal of Pharmaceutical Sciences 61: 903–905 (1972).
McCall, C.E.; Steigbigel, N.H. and Finland, M.: Lincomycin activity in vitro. and absorptio. and excretion in normal young men. American Journal of Medical Sciences 254: 144–155 (1967).
McCarthy, C.G. and Finland, M.: Absorptio. and excretion of four penicillins; penicillin G, penicillin V, phenethicilli. and phenylmercaptomethyl penicillin. New England Journal of Medicine 263: 315–326 (1960).
McCracken Jr, G.H.; Ginsburg, C.M.; Clahsen, J.C. and Thomas, M.L.: Pharmacologic evaluation of orally administered antibiotics in infant. and children: Effect of feeding on bioavailability. Pediatrics 62: 738–743 (1978).
MacDonald, H.; Place, V.A.; Falk, H. and Darken, M.A.: Effect of food on absorption of sulfonamides in man. Chemotherapia 12: 282–285 (1967).
Magni, L. and Sjövall, J.: Absorption of ampicilli. and pivampicillin in relation to food intake. Farmaceutisk Tidende 32: 645–648 (1972).
Malmborg, A.-S.: Effect of food on absorption of erythromycin. A study of two derivatives, the stearat. and the base. Journal of Antimicrobial Chemotherapy 5: 591–599 (1979).
Manninen, V.; Apajalahti, A.; Simonen, H. and Reissell, P.: Effect of propanthelin. and metoclopramide on absorption of digoxin. Lancet 1: 1118 (1973a).
Manninen, V.; Melin, J.; Apajalahti, A. and Karesoja, M.: Altered absorption of digoxin in patients given propranthelin. and metoclopramide. Lancet 1: 398–399 (1973b).
Männistö, P.: The effect of crystal size, gastric conten. and emptying rate on the absorption of nitrofurantoin in healthy human volunteers. International Journal of Clinical Pharmacology 16: 223–228 (1978).
Männistö, P.T.; Mäntylä, R.; Nykänen, S.; Lamminsivu, U. and Ottoila, P.: Impairing effect of food on ketoconazole absorption. Antimicrobial Agent. and Chemotherapy 21: 730–733 (1982).
Mäntylä, R.; Allonen, H.; Kanto, J.; Kleimola, T. and Sellman, R.: Effect of food on bioavailability of labetalol. British Journal of Clinical Pharmacology 9: 435–437 (1980).
Mattok, G.L. and McGilveray, I.J.: The effect of food intak. and sleep on the absorption of acetaminophen. Revue Canadienne de Biologie 32: 77–84 (1973).
Melander, A.: Influence of food on the bioavailability of drugs. Clinical Pharmacokinetics 3: 337–351 (1978).
Meiander, A.; Berlin-Wahlin, A.; Bodin, N.O.; Danielson, K.; Gustafsson, B.; Lindgren, S. and Westerlund, D.: Bioavailability of d-propoxyphene, acetyl salicylic acid. and phenazone in a combination tablet (Doleron£): Inter-individual variatio. and influence of food intake. Acta Medica Scandinavica 202: 119–124 (1977a).
Melander, A.; Brante, G.; Johansson, Ö.; Lindberg, T. and Wåhlin-Bol, E.: Influence of food on the absorption of phenytoin in man. European Journal of Clinical Pharmacology 15: 269–274 (1979a).
Melander, A.; Danielson, K.; Hanson, A.; Jansson, L.; Rerup, C.; Schemén, B.; Thulin, T. and Wåhlin, E.: Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Medica Scandinavica 200: 93–97 (1976a).
Melander, A.; Danielson, K.; Hanson, A.; Rudell, B.; Scherstén, B.; Thulin, T. and Wåhlin, E.: Enhancement of hydralazine bioavailability by food. Clinical Pharmacolog. and Therapeutics 22: 104–107 (1977b).
Melander, A.; Danielson, K.; Scherstén, B.; Thulin, T. and Wåhlin, E.: Enhancement by food of canrenone bioavailability from spironolactone. Clinical Pharmacolog. and Therapeutics 22: 100–103 (1977c).
Melander, A.; Danielson, K.; Scherstén, B. and Wåhlin, E.: Enhancement of the bioavailability of propranolo. and metoprolol by food. Clinical Pharmacolog. and Therapeutics 22: 108–112 (1977d).
Melander, A.; Danielson, K.; Vessman, J. and Wåhlin, E.: Bioavailability of oxazepam: Absence of influence of food intake. Acta Pharmacologica et Toxicologica 40: 584–588 (1977e).
Melander, A.; Kahlmeter, G.; Kamme, C. and Ursing, B.: Bioavailability of metronidazole in fastin. and non-fasting healthy subject. and in patients with Crohn’s disease. European Journal of Clinical Pharmacology 12: 69–72 (1977f).
Melander, A. and McLean, A.: Influence of food intake on pre-systemic clearance of drugs. Clinical Pharmacokinetics 8: 286–296 (1983).
Melander, A; Stenberg, P.; Liedholm, H.; Scherstén, B. and Wålin-Boll, E.: Food-induced reduction in bioavailability of aten-olol. European Journal of Clinical Pharmacology 16: 327–330 (1979b).
Melander, A. and Wåhlin, E.: Enhancement of dicoumarol bioavailability by concomitant food intake. European Journal of Clinical Pharmacology. 14: 441–444 (1978).
Melander, A.; Wåhlin, E.; Danielson, K. and Hanson, A.: Bioavailability of propylthiouracil: Interindividual variatio. and influence of food intake. Acta Medica Scandinavica 20: 41–44 (1977g).
Melander A.; Wåhlin, E.; Danielson, K. and Rerup, C.: On the influence of concomitant food intake on sulfonamide bioavailability. Acta Medica Scandinavica 200: 497–500 (1976b).
Meyers, B.R.; Kaplan, K. and Weinstein, L.: Cephalexin: Microbiological effect. and pharmacologic parameters in man. Clinical Pharmacolog. and Therapeutics 10: 810–816 (1969).
Mischler, T.W.; Sugerman, A.A.; Willard, D.A.; Brannick, L.J. and Neiss, E.S.: Influence of probeneci. and food on the bioavailability of cephradine in normal male subjects. Journal of Clinical Pharmacology 14: 604–611 (1974).
Moore, R.B.; Crane, C.A. and Frantz Jr, I.D.: Effect of chole-styramine on the fecal excretion of intravenously administered cholesterol-4-14. and its degradation productions in a hypercholesterolemic patient. Journal of Clinical Investigation 47: 1664–1671 (1968).
Morris, J.G.L.; Parsons, R.L.; Trounce, J.R. and Groves, M.J.: Plasma dopa concentrations after different preparations of levodopa in normal subjects. British Journal of Clinical Pharmacology 3: 983–990 (1976).
Münst, G.J.; Karlaganis, G. and Bircher, J.: Plasma concentrations of mebendazole during treatment of Echinococcosis. European Journal of Pharmacology 17: 375–378 (1980).
Naggar, V.F. and Khalil, S.A.: Effect of magnesium trisilicate on nitrofurantoin absorption. Clinical Pharmacolog. and Therapeutics 25: 857–863 (1979).
Neu, H.C.: Antimicrobial activit. and human pharmacology of amoxicillin. Journal of Infectious Diseases 129(Suppl.): S123–S131 (1974).
Neuvonen, P.J., Elfving, S.M. and Elonen, E.: Reduction of absorption of digoxin, phenytoi. and aspirin by activated charcoal in man. European Journal of Clinical Pharmacology 13: 213–218 (1978).
Neuvonen, P.J. and Elonen, E.: Effect of activated charcoal on absorptio. and elimination of phenobarbitone, carbamaze-pin. and phenylbutazone in man. European Journal of Clinical Pharmacology 17: 51–57 (1980).
Neuvonen, P.J.; Gothini, G.; Hackman, R. and af Björksten, K.: Interference of iron with the absorption of tetracyclines in man. British Medical Journal 4: 532–534 (1970).
Neuvonen, P.; Mattila, M.; Gothini, G. and Hackman, R.: Interference of iro. and milk with absorption of tetracycline. Scandinavian Journal of Laboratory Investigation 27(Suppl.): 76 (1971).
Neuvonen, P.J.; Pentikäinen, P.J. and Gothoni, G.: Inhibition of iron absorption by tetracycline. British Journal of Clinical Pharmacology 2: 94–96 (1975).
Neuvonen, P.J. and Penttilå, O.: Effect of oral ferrous sulphate on the half-life of doxycycline in man. European Journal of Clinical Pharmacology 7: 361–363 (1974).
Neuvonen, P.J. and Turakka, H.: Inhibitory effect of various iron salts on the absorption of tetracycline in man. European Journal of Clinical Pharmacology 7: 357–360 (1974).
Niazi, S.: Textbook of Biopharmaceutic. and Clinical Pharmacokinetics pp. 7–73 (Appleton-Century-Craft, New York 1979).
Nimmo, J.; Heading, R.C.; Tothill, P. and Prescott, L.F.: Pharmacological evaluation of gastric emptying: Effects of propanthelin. and metoclopramide on paracetamol absorption. British Medical Journal 1: 587–589 (1973).
Nimmo, W.S.; Heading, R.C.; Wilson, J.; Tothill, P. and Prescott, L.F.: Inhibition of gastric emptyin. and drug absorption by narcotic analgesics. British Journal of Clinical Pharmacology 2: 509–513 (1975).
Northcutt, R.C.; Stiel, J.N.; Hollifield, J.W. and Stant Jr, E.G.: The influence of cholestyramine on thyroxine absorption. Journal of the American Medical Association 208: 1857–1861 (1969).
Ohnhaus, E.E.: The effect of antaci. and food on the absorption of proquazone (Biarison) in man. International Journal of Clinical Pharmacology 18: 136–139 (1980).
Osman, M.A.; Patel, R.B.; Irwin, D.S. and Welling, P.G.: Absorption of theophylline from enteric coate. and sustained release formulations in faste. and nonfasted subjects. Biopharmaceutic. and Drug Disposition 4: 63–72 (1983).
Osman, M.A. and Welling, P.G.: Influence of propanthelin. and metoclopramide on the bioavailability of chlorothiazide. Current Therapeutic Research 34: 404–408 (1983).
Palva, I.P.; Rytkönen, U.; Aiatulkkila, M. and Palva, H.L.A.: Druginduced malabsorption of vitamin B12. Scandinavian Journal of Haematology 9: 5–7 (1972).
Pantuck, E.J.; Pantuck, C.B. and Conney, A.H.: Stimulatory effect of brussel sprout. and cabbage on human drug metabolism. Clinical Pharmacolog. and Therapeutics 25: 88–95 (1979).
Parsons, R.L.; Hossack, G.A. and Paddock, G.M.: Pharmacokinetics of pivmecillinam. British Journal of Clinical Pharmacology 4: 267–273 (1977).
Parsons, R.L. and Paddock, G.M.: Absorption of two antibacterial drugs, cephalexi. and co-trimoxazole, in malabsorption syndromes. Journal of antimicrobial Chemotherapy 1(Suppl.): 59–67 (1975).
Patel, R.B.; Patel, U.R.; Rogge, M.C.; Shah, V.P.; Prasad, V.K.; Selen, A. and Welling, P.G.: Bioavailability of hydrochlorothiazide from tablet. and suspensions. Journal of Pharmaceutical Sciences 73: 359–361 (1984).
Peck Jr., F.B. and Griffith, R.S.: Comparative clinical laboratory studies of potassium penicillin V with acid penicillin V; in Antibiotics Annual, 1957–1958, pp. 1004–1014 (Medical Encyclopedia Inc., 1958).
Pedersen, S.: Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food. British Journal of Clinical Pharmacology 12: 904–905 (1981).
Penttilä, O.; Hurme, H. and Neuvonen, P.J.: Effect of zinc sulphate on the absorption of tetracyclin. and doxycycline in man. European Journal of Clinical Pharmacology 9: 131–134 (1975).
Peterson, O.L.; Finland, M. and Ballou, A.N.: The effect of foo. and alkali on the absorptio. and excretion of sulfonamide drugs after ora. and duodenal administration. American Journal of Medical Science 204: 581–588 (1942).
Pilbrant, A.; Schannong, M. and Vessman, J.: Pharmacokinetic. and bioavailability of tranexamic acid. European Journal of Clinical Pharmacology 20: 65–72 (1981).
Poiger, H. and Schlauer, C.: Compensation of dietary induced reduction of tetracycline absorption by simultaneous administration of EDTA. European Journal of Clinical Pharmacology 14: 129–131 (1978).
Raeburn, J.A. and Devine, J.D.: Clindamycin levels in sputum in a patient with purulent chest disease due to cystic fibrosis. Postgraduate Medical Journal 47: 366–367 (1971).
Resetarits, D.E. and Bates, T.R.: Apparent dose-dependent absorption of chlorothiazide in dogs. Journal of Pharmacokinetic. and Biopharmaceutics 7: 463–470 (1979).
Rivera-Calimlim, L.; Castaneda, L. and Lasagna, L.: Effects of mode of management on plasma chlorpromazine in psychiatric patients. Clinical Pharmacolog. and Therapeutics 14: 978–985 (1973).
Rivera-Calimlim, L.; Dujovne, C.A.; Morgan, J.P.; Lasagna, L. and Bianchine, J.R.: Absorptio. and metabolism of l-dopa by the human stomach. European Journal of Clinical Investigation 1: 313–320 (1971).
Robinson, D.S.; Benjamin, D.M. and McCormack, J.J.: Interaction of warfari. and nonsystemic gastrointestinal drugs. Clinical Pharmacolog. and Therapeutics 12; 491–495 (1971).
Roe, D.A.: Drug-nutrient interactions. Residen. and Staff Physician 27: 42–48 (1981).
Roholt, K.; Nielsen, B. and Kristensen, E.: Clinical pharmacology of pivampicillin. Antimicrobial Agent. and Chemotherapy 6: 563–571 (1974).
Rosenberg, H.A. and Bates, T.R.: The influence of food on nitro-furantoin bioavailability. Clinical Pharmacolog. and Therapeutics 20: 227–232 (1976).
Rosenblatt, J.E.; Barrett, J.E.; Brodie, J.L. and Kirby, W.M.M.: Comparison of in vitro activit. and clinical pharmacology of doxycycline with other tetracyclines. Antimicrobial Agent. and Chemotherapy 1966: 134–141 (1967).
Rowland, M. and Tozer, T.N.: Clinical Pharmacokinetics. Concept. and Applications, pp. 16–33 (Le. and Febige, Philadelphia 1980).
Salokannel, S.J.; Palva, I.P. and Tukkunen, J.T.: Malabsorption of vitamin B12 during treatment with slow-release potassium chloride. Preliminary report. Acta Medica Scandinavica 187: 431–432 (1970).
Sanchez, N.; Sheiner, L.B.; Halkin, H. and Melmon, K.L.: Pharmacokinetics of digoxin: Interpreting bioavailability. British Medical Journal 4: 132–134 (1973).
Sartor, G.; Melander, A.; Scherstén, B. and Wåhlin-Boll, E.: Influence of foo. and age on the single-dose kinetic. and effects of tolbutamid. and chlorpropamide. European Journal of Clinical Pharmacology 17: 285–295 (1980).
Schreiner, J. and Altemeier, W.A.: Experimental study of factors inhibiting absorptio. and effective therapeutic levels of declomycin. Surger, Gynecolog. and Obstetrics 114: 9–14 (1962).
Schuna, A.; Osman, M.A.; Patel, R.B.; Welling, P.G. and Sundstrom, W.P.: Influence of food on the bioavailability of penicillamine. Journal of Rheumatology 10: 95–97 (1983).
Seed, J.C. and Wilson, C.E.: The effect of aluminum hydroxide on serum Aureomycin concentrations after simultaneous oral administration. Bulletin of the Johns Hopkins Hospital 86: 415–418 (1950).
Seneca, H. and Peer, P.: Enhancement of bloo. and urine tetracycline levels with a chymotrypsin-tetracycline preparation. Journal of the American Geriatrics Society 13: 708–717 (1965).
Sennello, L.T.; Sonders, R.G. and Friedman, N.: Effect of food on kinetics of the nonsteroidal antiinflammative alclofenac. Clinical Pharmacolog. and Therapeutics 23: 414–420 (1978).
Shader, R.I.; Georgotas, A.; Greenblatt, D.J.; Harmatz, J.S. and Allen, M.D.: Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide. Clinical Pharmacolog. and therapeutics 24: 308–315 (1978).
Siegler, D.I.; Bryant, M.; Burley, D.M.: Citron, K.M. and Standen, S.M.: Effect of meals on rifampicin absorption. Lancet 2: 197–198 (1974).
Singhvi, S.M.; McKinstry, D.N.; Shaw, J.M.; Willard, D.A. and Migdalof, B.H.: Effect of food on the bioavailability of captopril in healthy subjects. Journal of Clinical Pharmacology 22: 135–140 (1982).
Sorby, D.L. and Liu, G.: Effects of adsorbents on drug absorption. II. Effect of an antidiarrhea mixture on promazine absorption Journal of Pharmaceutical Sciences 55: 504–510 (1966).
Spiers, A.S.D. and Malone, H.R.: Effect of food on aspirin absorption. Lancet 1: 440 (1967).
Talbot, J.M. and Meade, B.W.: Effect of silicones on the absorption of anticoagulant drugs. Lancet 1: 1292 (1971).
Tamassia, V.; Corvi, G.; Mora, E.; Tosolini, G.P. and Fuccella, L.M.: Effect of food on absorption of indoprofen administered orally to man in two dosage forms. International Journal of Clinical Pharmacology 15: 389–393 (1977).
Tembo, A.V.; Sakmar, E.; Hallmark, M.R.; Weidler, D.J. and Wagner, J.G.: Effect of food on the bioavailability of prednisone. Journal of Clinical Pharmacology 16: 620–624 (1976).
Tenconi, L.T.; Buniva, G.; Beretta, E. and Pagani, V.: Influence of food intake on the absorption of diftalone in man. International Journal of Clinical Pharmacology 15: 485–491 (1977).
Tetzlaff, T.R.; McCracke, Jr. G.H. and Thomas, M.L.: Bioavailability of cephalexin in children. Relationship to drug formulation. and meals. Journal of Pediatrics 92: 292–294 (1978).
Thomas, E.J.: Mechanic. and regulation of gastric emptying. Physiological Reviews 37: 453–474 (1957).
Thompson, G.R.; Barrowman, J.; Gutierrez, L. and Dowling, R.H.: Action of neomycin on the intraluminal phase of lipid absorption. Journal of Clinical Investigation 50: 319–323 (1971).
Toothaker, R.D. and Welling, P.G.: The effect of food on drug bioavailability. Annual Review of Pharmacolog. and Toxicology 20: 173–199 (1980).
Volans, G.N.: Effects of foo. and exercise on the absorption of effervescent aspirin. British Journal of Clinical Pharmacology 1: 137–141 (1974).
Wagner, J.G.: Desig. and data analysis of biopharmaceutical studies in man. Canadian Journal of Pharmaceutical Sciences 1: 55–68 (1966).
Wagner, J.G.: Aspects of pharmacokinetic. and biopharmaceutics in relation to drug activity. American Journal of Pharmacy 141: 5–20 (1969).
Wåhlin-Boll, E.; Melander, A.; Sartor, G. and Schemén, B.: Influence of food intake on the absorptio. and effect of glipizide in diabetic. and in healthy subjects. European Journal of Clinical Pharmacology 18: 279–283 (1980).
Waisbren, B.A. and Hueckel, J.S.: Reduced absorption of Aureomycin caused by aluminium hydroxide gel (Amphojel). Proceedings of the Society for Experimental Biolog. and Medicine 73: 73–74 (1950).
Waiden, R.J.; Hernandez, R.; Witts, D.; Graham, B.R. and Prichard, B.N.C.: Effect of food on the absorption of hydralazine in man. European Journal of Clinical Pharmacology 20: 53–58 (1981).
Watanakunakorn, C.: Absorption of orally administered nafcillin in normal healthy volunteers. Antimicrobial Agent. and Chemotherapy 11: 1007–1009 (1977).
Welling, P.G.: How foo. and fluid affect drug absorption. Postgraduate Medicine 62: 73–82 (1977a).
Welling, P.G.: Influence of foo. and diet on gastrointestinal drug absorption: A review. Journal of Pharmacokinetic. and Biopharmaceutics 5: 291–334 (1977b).
Welling, P.G.: Drug bioavailabilit. and its clinical significance. Progress in Drug Metabolism 4: 131–163 (1980a).
Welling, P.G.: Effect of food on bioavailability of drugs. Pharmacy International 1: 14–18 (1980b).
Welling, P.G. and Barbhaiya, R.H.: Influence of foo. and fluid volume on chlorothiazide bioavailability: Comparison of plasm. and urinary excretion methods. Journal of Pharmceutical Sciences 71: 32–35 (1982).
Welling, P.G.: Barbhaiya, R.H.; Patel, R.B.; Foster, T.S.; Shah, V.P.; Hunt, J.P. and Prasad, V.K.: Thiazides, X. Lack of dose proportionality in plasma chlorothiazide levels following oral solution doses. Current Therapeutic Research 31: 379–385 (1982).
Welling, P.G.; Elliott, R.L.; Pitterle, M.E.; Corrick-West, H.P. and Lyons, L.L.: Plasma levels following singl. and repeated dose of erythromycin estolat. and erythromycin stearate. Journal of Pharmaceutical Sciences 68: 150–155 (1979).
Welling, P.G.; Huang, H.; Koch, P.A.; Craig, W.A. and Madsen, P.O.: Bioavailability of ampicilli. and amoxicillin in faste. and nonfasted subjects. Journal of Pharmaceutical Sciences 66: 549–552 (1977a).
Welling, P.G.; Kendall, M.J.; Dean, S.; Wise, R. and Andrews, J.M.: Effect of food on the bioavailability of alafosfalin, a new antibacterial agent. Journal of Antimicrobial Chemotherapy 6: 373–379 (1980).
Welling, P.G.; Koch, P.A.; Lau, C.C. and Craig, W.A.: Bioavailability of tetracyclin. and doxycycline in faste. and nonfasted subjects. Antimicrobial Agent. and Chemotherapy 11: 462–469 (1977b).
Welling, P.G.; Lyons, L.L.; Craig, W.A. and Trochta, G.A.: Influence of die. and fluid on bioavailability of theophylline. Clinical Pharmacolog. and Therapeutics 17: 475–480 (1975a).
Welling, P.G.; Lyons, L.L.; Elliot, R. and Amidon, G.L.: Pharmacokinetics of alcohol following single low doses to faste. and nonfasted subjects. Journal of Clinical Pharmacology 17: 199–206 (1977c).
Welling, P.G.; Lyons, L.L.; Tse, F.L.S. and Craig, W.A.: Propoxyphen. and norpropoxyphene: Influence of die. and fluid on plasma levels. Clinical Pharmacolog. and Therapeutics 19: 559–565 (1975b).
Welling, P.G. and Tse, F.L.S: The influence of food on the absorption of antimicrobial agents. Journal of Antimicrobial Chemotherapy 9: 7–27 (1982).
Willis, J.V.; Jack, D.B.; Kendall, M.J. and John, V.A.: The influence of food on the absorption of diclofenac as determined by the urinary excretion of unchanged dru. and its major metabolites during chronic administration. European Journal of Clinical Pharmacology 19: 39–44 (1981a).
Willis, J.V.; Kendall, M.J. and Jack, D.B.: The influence of food on the absorption of diclofenac after singl. and multiple oral doses. European Journal of Clinical Pharmacology 19: 33–37 (1981b).
Woo, E. and Greenblatt, D.J.: Effect of food on enterai absorption of quinidine. Clinical Pharmacolog. and Therapeutics 27: 188–193 (1980).
Wood, J.H.: Effect of food on aspirin absorption. Lancet 2: 212 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Welling, P.G. Interactions Affecting Drug Absorption. Clin Pharmacokinet 9, 404–434 (1984). https://doi.org/10.2165/00003088-198409050-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198409050-00002